Immunome Inc (IMNM)

R&D to Revenue

2511.61%

Fiscal year · Period ending:

IMNM logo

IMNM R&D to Revenue

Latest reported2511.61%
IMNM FY R&D/Revenue (0.00% → 2511.61%)
High-resolution chart · PNG

IMNM r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
2,511.6122%
1,432.8282%
164.7097%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.